A company that develops integrated photonics to create highly sensitive and selective biosensors
Delta Diagnostics has raised €5.3M across 1 funding round from 4 investors, most recently a Series A round in May 2023. Based in Amsterdam, Netherlands; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-05-12 | Series A | €5.3M |
| i&i Biotech Fund,InnovationQuarter,Oost NL,PhotonDelta |
| View deal → |
